亨廷顿蛋白
突变体
细胞生物学
聚谷氨酰胺束
生物
激酶
SH3域
亨廷顿蛋白
分子生物学
生物化学
基因
原癌基因酪氨酸蛋白激酶Src
作者
Scott T. Brady,Nichole A. Mesnard‐Hoaglin,Sarah Mays,Mercedes Priego,Joanna Dziechciowska,Sarah Morris,Minsu Kang,Ming Tsai,Jennifer L. Purks,Alison Alfred Klein,Angelica Gaona,Alexandra Melloni,Theresa R. Connors,Bradley T. Hyman,Yuyu Song,Gerardo Morfini
出处
期刊:Brain
[Oxford University Press]
日期:2023-08-26
卷期号:147 (6): 2098-2113
被引量:3
标识
DOI:10.1093/brain/awad280
摘要
Huntington's disease results from expansion of a polyglutamine tract (polyQ) in mutant huntingtin (mHTT) protein, but mechanisms underlying polyQ expansion-mediated toxic gain-of-mHTT function remain elusive. Here, deletion and antibody-based experiments revealed that a proline-rich domain (PRD) adjacent to the polyQ tract is necessary for mHTT to inhibit fast axonal transport and promote axonal pathology in cultured mammalian neurons. Further, polypeptides corresponding to subregions of the PRD sufficed to elicit the toxic effect on fast axonal transport, which was mediated by c-Jun N-terminal kinases (JNKs) and involved PRD binding to one or more SH3-domain containing proteins. Collectively, these data suggested a mechanism whereby polyQ tract expansion in mHTT promotes aberrant PRD exposure and interactions of this domain with SH3 domain-containing proteins including some involved in activation of JNKs. In support, biochemical and immunohistochemical experiments linked aberrant PRD exposure to increased JNK activation in striatal tissues of the zQ175 mouse model and from post-mortem Huntington's disease patients. Together, these findings support a critical role of PRD on mHTT toxicity, suggesting a novel framework for the potential development of therapies aimed to halt or reduce axonal pathology in Huntington's disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI